TerminatedNot Applicable

Staging Procedures to Diagnose Malignant Pleural Mesothelioma

Stopped: due to low/slow accrual

United States33 participantsStarted 2016-01-15

Plain-language summary

The purpose of this study is to evaluate the accuracy of participants imaging versus staging procedures. The investigators will consent subjects that are scheduled to undergo staging procedures to diagnose malignant pleural mesothelioma (including pleuroscopy, bronchoscopy, endobronchial ultrasound and laparoscopy) as part of their standard of care.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Subject provides informed consent * Subject is \>18 years of age * Subject is deemed competent for making medical decisions * Subject is scheduled to undergo a staging pleuroscopy * Subject is a surgical candidate * A negative pregnancy test is required in women of child-bearing potential, as standard of care. Exclusion Criteria: * Subject is \<18 years old.

What they're measuring

Accuracy of surgical staging versus imaging procedures based on surgical findings.

Timeframe: 2 years

Trial details

NCT IDNCT02648763

SponsorMayo Clinic

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-04-22

View on ClinicalTrials.gov More Mesothelioma trials